Olga Kubassova, PhD[email protected]Nuclear MedicineHow medical imaging can accelerate drug developmentIt can take 15 years to get a drug candidate from the lab to approval. Could medical imaging speed up that process? Olga Kubassova, PhD, of Image Analysis Group explains how imaging modalities such as MRI, CT, and PET are helping to track biomarkers in clinical studies, potentially bringing lifesaving therapies to patients more quickly.January 21, 2019Page 1 of 1Top StoriesRadiation Oncology/TherapyStudy highlights value of radiologist involvement in RT planningRadiologist peer review improves the rate of clinically meaningful changes to radiation therapy (RT) planning, researchers have reported.CTThe challenges of dysrhythmic radiologistsBreastWomen with BRCA1/2 germline mutations are often denied breast MRIWomens ImagingStarting breast cancer screening at 40 is more cost-effectiveMolecular ImagingPSMA-PET/CT bests conventional imaging for prostate cancer diagnosis
